The FTC sued to block the Amgen (AMGN) and Horizon Therapeutics (HZNP) deal. Renita Young discusses how AMGN is in talks to acquire HZNP. The FTC is concerned about AMGN "bundling" medicines if the deal goes thorough. AMGN is "disappointed" by the lawsuit and calls the FTC's concerns "speculative." Tune in to find out more about the stock market today.
16 May 2023
Trading 360
28 Aug 2023
Morning Trade Live
21 Jul 2023
Morning Trade Live
06 Sep 2023
The Watch List
26 Sep 2023
Trading 360
11 Jul 2023
Fast Market
26 Sep 2023